Venture Capital

HIP Fund

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Series A, Growth, Late Stage

Geographical Focus
United States

Industries Focus

  • Healthcare
  • Life Sciences
  • Digital Health
  • Diagnostics
  • Medtech
  • Health IT
  • Screening

Investment Size:
1,000,000 to 10,000,000 USD

Investor Details Founded: 2024

HIP Fund is an opportunistic, healthcare-focused venture capital firm built with—and for—a community of seasoned investors. Its network includes non-institutional investors (such as angels, family offices, and physicians) alongside institutional investors (including VCs, health systems, and strategics), who collaborate to conduct diligence and make collective investment decisions in innovative healthcare startups. HIP portfolio companies are backed by a strong syndication of influential health investors and further supported by industry titans who provide guidance on strategy and execution. This is amplified by the HIP collaborative ecosystem and affiliate partners, delivering a turnkey, full lifecycle venture model.

HIP offers a unique opportunity to see pre-selected healthcare startups that undergo an extensive collaborative diligence process aligned with investor criteria, while also providing the chance to network with other investors and healthcare experts. The firm focuses exclusively on healthcare, investing in digital health, health tech, tech-enabled services, health IT, and life sciences (medical devices, diagnostics, and screening). HIP does not invest in drug discovery, drug development, or biotechnology.

As of late 2024, HIP's portfolio includes 12 early-stage healthcare technology companies, with over 75% having received multiple rounds of funding from the HIP ecosystem. The firm conducts investor meetings virtually to accommodate investors across multiple time zones and occasionally hosts in-person meetings. Startups seeking investment must complete a sign-up and application process to be considered for presentation at a HIP investor meeting.

HIP's collaborative diligence model leads to the selection of disruptive healthcare startups worthy of multifaceted capital deployment. The firm emphasizes a community-based diligence approach and an end-to-end white-glove investment process, aiming to expedite the investment process for startups and provide investors with highly curated opportunities.

HIP's mission is to advance healthcare by investing in disruptive startups, leveraging a network of over 150 investors, and providing strategic capital to accelerate the growth of innovative healthcare companies. The firm is committed to fostering a collaborative ecosystem that supports both investors and startups in achieving their goals.

For more information or to join the investor network, visit HIP's official website or contact them through the provided channels.

Requirements
  • Accredited investors
  • Healthcare-focused startups
  • Digital health, health tech, tech-enabled services, health IT, life sciences (medical devices, diagnostics, and screening)
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

Portfolio Companies
  • RCE Infrasensor
  • Diasyst
  • Medzoomer
  • Cooler Heads Care
  • Circular Genomics
  • OxiWear
  • Sonara
  • Nudj
  • Beacon
  • Hipp Health
Claim this Investor

Are you an official representative of HIP Fund?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim